A recent study published in The Lancet Infectious Diseases journal reveals that the use of metformin, a widely available and low-cost diabetes medication, reduces the risk of developing long COVID by 41 percent. Meanwhile, ivermectin, another drug that has been the subject of much debate and scrutiny, showed no significant impact on the incidence of…
US Regulators Reject Request to Clear Cheap Drug for Treatment of COVID-19
May 19, 2022
admin
BrightCCP VirusCovid NewsEditor's PicksfluvoxamineFood and Drug AdministrationhealthHealth NewsPUBLIC HEALTH INFORMATION
0 Comment
U.S. regulators have rejected a request to grant emergency authorization to a cheap drug for the treatment of COVID-19, drawing criticism from one of the doctors that asked for the clearance. The Food and Drug Administration (FDA), in a 27-page memorandum explaining its decision, said that the benefit of fluvoxamine was “not persuasive when focusing…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`